BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yan R, Dai W, Wu R, Huang H, Shu M. Therapeutic targeting m6A-guided miR-146a-5p signaling contributes to the melittin-induced selective suppression of bladder cancer. Cancer Letters 2022;534:215615. [DOI: 10.1016/j.canlet.2022.215615] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Mei Z, Mou Y, Zhang N, Liu X, He Z, Gu S. Emerging Mutual Regulatory Roles between m(6)A Modification and microRNAs. Int J Mol Sci 2023;24. [PMID: 36614216 DOI: 10.3390/ijms24010773] [Reference Citation Analysis]
2 Wen X, Wang J, Wang Q, Liu P, Zhao H. Interaction between N6-methyladenosine and autophagy in the regulation of bone and tissue degeneration. Front Bioeng Biotechnol 2022;10:978283. [DOI: 10.3389/fbioe.2022.978283] [Reference Citation Analysis]
3 Cai X, Liang C, Zhang M, Xu Y, Weng Y, Li X, Yu W. N6-methyladenosine modification and metabolic reprogramming of digestive system malignancies. Cancer Letters 2022. [DOI: 10.1016/j.canlet.2022.215815] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Mao Y, Li W, Weng Y, Hua B, Gu X, Lu C, Xu B, Xu H, Wang Z. METTL3-Mediated m6A Modification of lncRNA MALAT1 Facilitates Prostate Cancer Growth by Activation of PI3K/AKT Signaling. Cell Transplant 2022;31:9636897221122997. [PMID: 36073002 DOI: 10.1177/09636897221122997] [Reference Citation Analysis]